The community suggests prioritizing dietary supplements based on consensus among longevity experts rather than the protocol of a single media figure, favoring universally validated pillars (Omega-3s, creatine, magnesium, zinc, vitamin D) and remaining cautious of specialized molecules with weak cross-validation.

noli's read

The expert consensus cited in the thread aligns closely with current research: Omega-3s (meta-analyses on cardiovascular health), creatine (RCTs on performance and cognitive function), and magnesium/zinc (fundamental metabolic role) benefit from robust evidence. Vitamin D, while beneficial, is the subject of debate regarding systematic supplementation versus natural optimization, as highlighted by Attia (expert opinion based on homeostasis). Skepticism regarding NAD precursors (NMN/NR) is scientifically grounded in the fragility of human results and conflicting data from ITP programs (observational and preclinical studies), rendering the longevity benefit uncertain. Molecules such as Tongkat Ali sorely lack large-scale clinical trials, limiting their status to that of a niche tool without robust proof. Finally, the use of aggregated data to refine individual recommendations is a rational approach, although relying on expert opinions remains an indicator of popularity rather than absolute clinical proof. The community strongly converges toward this cross-validation, rejecting the idea of blindly following a single protocol.

the sources

1. 1NIH Office of Dietary Supplements 2026
2. 2NIH Office of Dietary Supplements 2026
3. 3Manson JE et al. 2019
4. 4Bhatt DL et al. 2019
5. 5NIH Office of Dietary Supplements 2026
6. 6r/HubermanLab